AU515236B2 - Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives - Google Patents

Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives

Info

Publication number
AU515236B2
AU515236B2 AU37471/78A AU3747178A AU515236B2 AU 515236 B2 AU515236 B2 AU 515236B2 AU 37471/78 A AU37471/78 A AU 37471/78A AU 3747178 A AU3747178 A AU 3747178A AU 515236 B2 AU515236 B2 AU 515236B2
Authority
AU
Australia
Prior art keywords
furyl
tetrahydro
thienyl
substituted
benzazepine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU37471/78A
Other versions
AU3747178A (en
Inventor
K. G. and Yim N. C. F Holden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Priority to AU37471/78A priority Critical patent/AU515236B2/en
Priority to NL7807819A priority patent/NL7807819A/en
Publication of AU3747178A publication Critical patent/AU3747178A/en
Application granted granted Critical
Publication of AU515236B2 publication Critical patent/AU515236B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU37471/78A 1978-06-26 1978-06-26 Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives Expired AU515236B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU37471/78A AU515236B2 (en) 1978-06-26 1978-06-26 Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives
NL7807819A NL7807819A (en) 1978-06-26 1978-07-21 Pharmaceutically active benzazepine cpds. - specifically, substd. 1-thienyl and furyl-2,34,5-tetra:hydro-1H-3-benzazepine(s)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU37471/78A AU515236B2 (en) 1978-06-26 1978-06-26 Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives
NL7807819A NL7807819A (en) 1978-06-26 1978-07-21 Pharmaceutically active benzazepine cpds. - specifically, substd. 1-thienyl and furyl-2,34,5-tetra:hydro-1H-3-benzazepine(s)

Publications (2)

Publication Number Publication Date
AU3747178A AU3747178A (en) 1980-01-03
AU515236B2 true AU515236B2 (en) 1981-03-26

Family

ID=25623985

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37471/78A Expired AU515236B2 (en) 1978-06-26 1978-06-26 Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives

Country Status (2)

Country Link
AU (1) AU515236B2 (en)
NL (1) NL7807819A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8299241B2 (en) 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9169213B2 (en) 2012-10-09 2015-10-27 Arena Pharmaceuticals, Inc. Method of weight management
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
US10226471B2 (en) 2010-09-01 2019-03-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045013A1 (en) * 1998-03-06 1999-09-10 Novo Nordisk A/S 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
CN102321023A (en) 2004-12-21 2012-01-18 艾尼纳制药公司 (R)-and 8-chloro-1-methyl-2,3,4, the crystal formation of 5-tetrahydrochysene-1H-3-benzazepine hydrochloride
AU2005322183B2 (en) 2004-12-23 2012-03-29 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8946207B2 (en) 2003-06-17 2015-02-03 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8299241B2 (en) 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
US9770455B2 (en) 2010-09-01 2017-09-26 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US10226471B2 (en) 2010-09-01 2019-03-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management
US10463676B2 (en) 2010-09-01 2019-11-05 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management
US9169213B2 (en) 2012-10-09 2015-10-27 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
AU3747178A (en) 1980-01-03
NL7807819A (en) 1980-01-23

Similar Documents

Publication Publication Date Title
AU522975B2 (en) Carbazolyl-(4)-oxypropanolamine derivatives
GB2035303B (en) 2,3-dicyano-hydroquinone derivatives
AU518432B2 (en) 3,4,5-trisubstituted-oxazolid and thiazolid-2-ones
AU515236B2 (en) Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives
AU529597B2 (en) 4-thia-1-aza-bicyclo-(3,2,0)-heptane and azetidin-2-one derivatives
AU529068B2 (en) 1,2,3,5-tetrahydroimidazothienopyrimidin-2-ones
AU4622079A (en) Substituted 1,3-diaryl-2-imino-imidazolidines and 2-imino- hexahydro-pyrimidines
AU517598B2 (en) Derivatives of 1-aza-(2,2,2)-bicyclo-octane
AU6494680A (en) 2,3-indoledione derivatives
AU5249179A (en) Methylene dioxybenzenes and benzo 1,4 dioxens
AU5118979A (en) 2,6-diaminoebularines
AU4668779A (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3- benzazepines
AU527243B2 (en) Antiiflammatory 4,5-diaryl-2-(substituted-thio) pyrroles
GB2048254B (en) 19,20 -didehydro-19-hydroxy and 19-oxo-prostaglandin derivatives
GB2017093B (en) 3,3-dichloro-2-azetidinone derivatives
AU529927B2 (en) 2,5-inter-o-phenylene-3,4-dinor-pgf and pgi compounds
AU529456B2 (en) 6,7-benzomorphan derivatives
AU550725B2 (en) 17,18-dehydrovincaminol derivatives and their preparation
AU522421B2 (en) "hydroisoquinolinium derivatives"
AU5476780A (en) 3:,4: - dideoxykanamycin a and derivatives
AU535319B2 (en) 1,2,4-imazine derivatives
AU512767B2 (en) 2,9-dioxatricyclo [4,3,1,03,7] decans and the preparation thereof
GB2072677B (en) 1-n-substituted 3',4'-didehydrokanamycin b derivatives
AU529932B2 (en) 3:,4:-diepi-4:-0-methyl-daunorubicin and derivatives
GB2013678B (en) 1,4 benzoazine derivatives